ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL2107841
CHEMBL2107841
Compound Name ALBIGLUTIDE
ChEMBL Synonyms ALBIGLUTIDE | GSK716155 | EPERZAN
Max Phase 4 (Approved)
Trade Names EPERZAN

Sources

  • British National Formulary
  • Manually Added Drugs
  • USP Dictionary of USAN and International Drug Names
  • WHO Anatomical Therapeutic Chemical Classification

Molecule Features

CHEMBL2107841 compound icon
Drug Type:Oligopeptide Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:N Parenteral:Y Topical:N Black Box:Y Availability Type:Prescription-only

Mechanism of Action

Mechanism of Action ChEMBL Target References
Glucagon-like peptide 1 receptor agonist Glucagon-like peptide 1 receptor FDA

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
Diabetes MellitusD003920EFO:0000400diabetes mellitus3ClinicalTrials
Diabetes Mellitus, Type 2D003924EFO:0001360type II diabetes mellitus4ClinicalTrials
DailyMed
Diabetes Mellitus, Type 1D003922EFO:0001359type I diabetes mellitus2ClinicalTrials
Heart FailureD006333EFO:0000373congestive heart failure2ClinicalTrials

Clinical Data

ClinicalTrials.gov ALBIGLUTIDE
The Cochrane Collaboration ALBIGLUTIDE

Compound Cross References

ATC A - ALIMENTARY TRACT AND METABOLISM
A10 - DRUGS USED IN DIABETES
A10B - BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BJ - Glucagon-like peptide-1 (GLP-1) analogues
A10BJ04 - albiglutide

ChemSpider ChemSpider Identifier not yet assigned
DailyMed albiglutide
spacer
spacer